Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)
China · Delayed Price · Currency is CNY 73.64
+0.19 (0.26%)
At close: Feb 13, 2026
SHE:301617 Revenue
Shandong Boyuan Pharmaceutical & Chemical had revenue of 326.68M CNY in the quarter ending September 30, 2025, with 4.84% growth. This brings the company's revenue in the last twelve months to 1.39B, up 8.45% year-over-year. In the year 2024, Shandong Boyuan Pharmaceutical & Chemical had annual revenue of 1.33B with 29.53% growth.
Revenue (ttm)
1.39B
Revenue Growth
+8.45%
P/S Ratio
7.06
Revenue / Employee
2.09M
Employees
667
Market Cap
9.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.33B | 302.73M | 29.53% |
| Dec 31, 2023 | 1.03B | 226.68M | 28.39% |
| Dec 31, 2022 | 798.47M | 274.10M | 52.27% |
| Dec 31, 2021 | 524.37M | 144.93M | 38.20% |
| Dec 31, 2020 | 379.44M | 41.13M | 12.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Suzhou Gold Mantis Construction Decoration | 16.98B |
| Shenzhen Hello Tech Energy | 4.41B |
| Wuxi Boton Technology | 3.31B |
| DongGuan YuTong Optical Technology | 3.11B |
| Guangdong Guanghua Sci-Tech | 2.80B |
| Kingsignal Technology | 2.42B |
| Jiangsu Pacific Precision Forging | 2.05B |
| Fujian Boss Software | 2.05B |